Comparative Analysis of Isolated Venous, Isolated Arterial, and Standard Access for Transcatheter Closure of Patent Ductus Arteriosus (PDA)

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06763978

Enrollment

357

Registered

2025-01-08

Start date

2020-01-01

Completion date

2024-01-31

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamically Significant PDA

Brief summary

We enrolled all patients with a hemodynamically significant PDA demonstrated by patient clinical condition, and by PDA size & left chamber dilatation on echocardiography attending at Cardiology Department to we compare the use of a single venous access and a single arterial access with the standard approach requiring both venous and arterial access for transcatheter PDA closure regarding the outcome & complications.

Interventions

DEVICETranscatheter PDA closure

Transcatheter PDA closure

Study design

Allocation

NON_RANDOMIZED

Intervention model

FACTORIAL

Primary purpose

OTHER

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* any patient with hemodynamically significant PDA

Exclusion criteria

* patient with pulmonary hypertension and Eisenmenger syndrome

Design outcomes

Primary

Measure	Time frame
procedural and fluoroscopy time	during the procedure

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026